CIN

1001 drugs in development·242 companies·1 clinical trial

Drug Pipeline by Phase

Approved(119)

Drug	Company
abrilada	PFIZER INC (PFE)
afinitor	Novartis AG (NVS)
Alinity® family	ABBOTT LABORATORIES (ABT)
Alinity® family of instruments	ABBOTT LABORATORIES (ABT)
amjevita	AMGEN INC (AMGN)
amoxicillin	Aptinyx Inc. (APTX)
amoxicillin	SUNSET ISLAND GROUP (SUN)
amoxicillin	Miromatrix Medical Inc. (MIRO)
avsola	AMGEN INC (AMGN)
axitinib	Aptinyx Inc. (APTX)
Aybintio (SB8)	Organon & Co. (OGN)
azithromycin	GT Biopharma, Inc. (GTBP)
azithromycin	Aptinyx Inc. (APTX)
azithromycin	SUNSET ISLAND GROUP (SUN)
bicalutamide	SUNSET ISLAND GROUP (SUN)
bicalutamide	Aptinyx Inc. (APTX)
breyna	Mylan II B.V. (MYL)
CABOMETYX	EXELIXIS, INC. (EXEL)
calcium gluconate in	Amneal Pharmaceuticals, Inc. (AMRX)
ceftriaxone	Teva Pharmaceutical Industries Limited (TEVA)
CellFX Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
cinacalcet	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	ANI PHARMACEUTICALS INC (ANIP)
ciprofloxacin	DR REDDYS LABORATORIES LTD (RDY)
ciprofloxacin	AMARIN CORP PLCUK (AMRN)
ciprofloxacin	SUNSET ISLAND GROUP (SUN)
ciprofloxacin	Prestige Consumer Healthcare Inc. (PBH)
ciprofloxacin	Altamira Therapeutics Ltd. (CYTOF)
clarithromycin	SUNSET ISLAND GROUP (SUN)
Clarithromycin Granules and Capsules	CHINA PHARMA HOLDINGS, INC. (CPHI)
cnj-016	Emergent BioSolutions Inc. (EBS)
colchicine	Mylan II B.V. (MYL)
cyclophosphamide	NEXUS BIOPHARMA INC (NEXS)
cyclosporine	Amneal Pharmaceuticals, Inc. (AMRX)
cyclosporine	Mylan II B.V. (MYL)
Cyramza	ELI LILLY & Co (LLY)
Cyramza®	ELI LILLY & Co (LLY)
daptomycin	MAIA Biotechnology, Inc. (MAIA)
docetaxel	Amneal Pharmaceuticals, Inc. (AMRX)
docetaxel	PFIZER INC (PFE)
doxorubicin	Amneal Pharmaceuticals, Inc. (AMRX)
Erivedge	CURIS INC (CRIS)
Ervebo	Merck & Co., Inc. (MRK)
erythromycin lactobionate	NEXUS BIOPHARMA INC (NEXS)
esoguard	Lucid Diagnostics Inc. (LUCD)
esomeprazole magnesium	EXELIXIS, INC. (EXEL)
fluocinonide	Amneal Pharmaceuticals, Inc. (AMRX)
fluorescein	NEXUS BIOPHARMA INC (NEXS)
gloperba	SCILEX HOLDING CO (SCLX)
GOCOVRI	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
guanfacine	Aptinyx Inc. (APTX)
guanfacine	Impax Laboratories, LLC (IPXL)
guanfacine	SUNSET ISLAND GROUP (SUN)
guanfacine	GH Research PLC (GHRS)
guanfacine	Nascent Biotech Inc. (NBIO)
halcinonide	Mylan II B.V. (MYL)
healthtronics ossatron	SANUWAVE Health Inc. (SNWV)
hydrocortisone	Aptinyx Inc. (APTX)
hydroxyurea	AVEDRO INC (AVDR)
imipramine	OXFORD IMMUNOTEC GLOBAL PLC (OXFD)
INDOCIN (suppositories and oral suspension)	Assertio Holdings, Inc. (ASRT)
indomethacin	Mylan II B.V. (MYL)
indomethacin	Amneal Pharmaceuticals, Inc. (AMRX)
Influvac™	ABBOTT LABORATORIES (ABT)
Klacid™ (Claribid™, Klaricid™)	ABBOTT LABORATORIES (ABT)
labeling	ACURA PHARMACEUTICALS, INC (ACUR)
Lenvima	Merck & Co., Inc. (MRK)
lidocaine	AlphaTON Capital Corp (ATON)
lidocaine	LUMOS PHARMA, INC. (NLNK)
lidocaine	NVN Liquidation, Inc. (NOVN)
loqtorzi	Coherus Oncology, Inc. (CHRS)
lymphoseek kit	Cardinal Health Inc. (CAH)
lyumjev	ELI LILLY & Co (LLY)
methylprednisolone	Amneal Pharmaceuticals, Inc. (AMRX)
minocin	MELINTA THERAPEUTICS, INC. /NEW/ (MLNT)
naloxone	Amneal Pharmaceuticals, Inc. (AMRX)
nPulse Console	Pulse Biosciences Inc Common Stock (DE) (PLSE)
ogivri	Mylan II B.V. (MYL)
olpruva	Acer Therapeutics Inc. (ACER)
ONGENTYS	Amneal Pharmaceuticals, Inc. (AMRX)
onivyde	MERRIMACK PHARMACEUTICALS INC (MACK)
Ontruzant (SB3)	Organon & Co. (OGN)
opdivo qvantig	BRISTOL MYERS SQUIBB CO (BMY)
phendimetrazine	ELITE PHARMACEUTICALS INC /NV/ (ELTP)
proleukin	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
Relistor	Bausch Health Companies Inc. (BHC)
renuvion	Apyx Medical Corporation (APYX)
Retevmo	ELI LILLY & Co (LLY)
Retevmo®	ELI LILLY & Co (LLY)
sodium	Amneal Pharmaceuticals, Inc. (AMRX)
sodium nitroprusside	NEXUS BIOPHARMA INC (NEXS)
sodium nitroprusside	Amneal Pharmaceuticals, Inc. (AMRX)
steviosin	SUNWIN STEVIA INTERNATIONAL, INC. (SUWN)
succinylcholine	NEXUS BIOPHARMA INC (NEXS)
tacrolimus	NEXUS BIOPHARMA INC (NEXS)
tacrolimus	Mylan II B.V. (MYL)
TechneLite	Lantheus Holdings, Inc. (LNTH)
tevimbra	BeOne Medicines Ltd. (ONC)
tobramycin	Amneal Pharmaceuticals, Inc. (AMRX)
triamcinolone acetonide	Miromatrix Medical Inc. (MIRO)
triamcinolone acetonide	Teva Pharmaceutical Industries Limited (TEVA)
Tyvyt	ELI LILLY & Co (LLY)
Tyvyt®	ELI LILLY & Co (LLY)
unloxcyt	Checkpoint Therapeutics, Inc. (CKPT)
unloxcyt	Fortress Biotech Inc. (FBIO)
unloxcyt	Fortress Biotech Inc. (FBIO)
ursodiol	Optec International, Inc. (GM)
varubi	TESARO, Inc. (TSRO)
vascepa	AMARIN CORP PLCUK (AMRN)
verkazia	HARROW, INC. (IMMY)
vigiv cnj-016	Emergent BioSolutions Inc. (EBS)
vykoura	Kaya Holdings, Inc. (KAYS)
wixela inhub	Mylan II B.V. (MYL)
XACDURO	Innoviva, Inc. (INVA)
XACDURO®	Innoviva, Inc. (INVA)
XADAGO	SUPERNUS PHARMACEUTICALS, INC. (SUPN)
Zenocutuzumab (Zeno) / BIZENGRI® (zenocutuzumab-zbco)	Merus N.V. (MRUS)
zioptan	AKORN INC (AKRX)
ZYNYZ	MACROGENICS INC (MGNX)

Phase 3(287)

Drug	Company
(osimertinib cohort	ASTRAZENECA PLC (AZN)
[18F]FAPI-74 PET/CT	ENANTA PHARMACEUTICALS INC (ENTA)
31-valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
5-flurouracil	GH Research PLC (GHRS)
5-FU	Tango Therapeutics, Inc. (TNGX)
Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
acp-103	ACADIA PHARMACEUTICALS INC (ACAD)
Adagrasib	ENANTA PHARMACEUTICALS INC (ENTA)
Adjuvant Systemic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
administration of lymphodepletion	GH Research PLC (GHRS)
Ameluz®	Biofrontera Inc. (BFRI)
amezalpat	Tempest Therapeutics, Inc. (TPST)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
amivantamab sc	GH Research PLC (GHRS)
Apalutamide	ARS Pharmaceuticals, Inc. (SPRY)
Apalutamide	Myovant Sciences Ltd. (MYOV)
Apalutamide	Crinetics Pharmaceuticals, Inc. (CRNX)
ARM C FOLFIRI	IGM Biosciences, Inc. (IGMS)
avelumab	GH Research PLC (GHRS)
avelumab	CG Oncology, Inc. (CGON)
Avelumab	Merus N.V. (MRUS)
Avelumab	Royalty Pharma plc (RPRX)
AZD0901	ASTRAZENECA PLC (AZN)
AZD2936	ASTRAZENECA PLC (AZN)
AZD5069	ASTRAZENECA PLC (AZN)
AZD8205 and AZD5305 and AZD2936	ASTRAZENECA PLC (AZN)
AZD9150	ASTRAZENECA PLC (AZN)
azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
azenosertib (ZN-c3)	Zentalis Pharmaceuticals, Inc. (ZNTL)
Background Chemotherapy	Merus N.V. (MRUS)
Balstilimab	ENANTA PHARMACEUTICALS INC (ENTA)
Base-edited hematopoietic stem and progenitor cells	Merus N.V. (MRUS)
batiraxcept	Aravive, Inc. (ARAV)
Bavituximab	Merck & Co., Inc. (MRK)
bcg	GH Research PLC (GHRS)
bcg tokyo-172 strain	GH Research PLC (GHRS)
Belzutifan	Merck & Co., Inc. (MRK)
BET Bromodomain Inhibitor ZEN-3694	Merus N.V. (MRUS)
bgb-a445	BeOne Medicines Ltd. (ONC)
BGB-A445	BeOne Medicines Ltd. (ONC)
Bicalutamide	ARS Pharmaceuticals, Inc. (SPRY)
brachytherapy	GH Research PLC (GHRS)
Cabazitaxel	KYNTRA BIO INC. (KYNB)
cabozantinib	GH Research PLC (GHRS)
Cabozantinib	Royalty Pharma plc (RPRX)
Cabozantinib	BRISTOL MYERS SQUIBB CO (BMY)
Cabozantinib S-malate	Royalty Pharma plc (RPRX)
Cadonilimab	Merus N.V. (MRUS)
Calcio levofolinate	IGM Biosciences, Inc. (IGMS)
Camrelizumab and Cetuximab	FATE THERAPEUTICS INC (FATE)
Camrelizumab and Chemotherapy	FATE THERAPEUTICS INC (FATE)
Camrelizumab and Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
CAN-2409	Candel Therapeutics, Inc. (CADL)
capmatinib	GH Research PLC (GHRS)
CAR-T cell	Filana Therapeutics Inc. (FLNA)
Casdatifan	ASTRAZENECA PLC (AZN)
casdatifan (AB521)	Arcus Biosciences, Inc. (RCUS)
Cemiplimab	ENANTA PHARMACEUTICALS INC (ENTA)
cemiplimab+fianlimab fixed dose combination	REGENERON PHARMACEUTICALS, INC. (REGN)
Ceralasertib	Relay Therapeutics, Inc. (RLAY)
Ceralasertib	Crinetics Pharmaceuticals, Inc. (CRNX)
Ceralasertib	ADMA BIOLOGICS, INC. (ADMA)
Ceralasertib	ENANTA PHARMACEUTICALS INC (ENTA)
cetuximab	GH Research PLC (GHRS)
cetuximab	Innovation Pharmaceuticals Inc. (IPIX)
cetuximab	ASTRAZENECA PLC (AZN)
cetuximab	JOHNSON & JOHNSON (JNJ)
cetuximab	AVEO PHARMACEUTICALS, INC. (AVEO)
Cetuximab	FATE THERAPEUTICS INC (FATE)
Cetuximab Sarotalocan Sodium	FATE THERAPEUTICS INC (FATE)
Cetuximab Sarotalocan Sodium	Amneal Pharmaceuticals, Inc. (AMRX)
CGT4859	Cogent Biosciences, Inc. (COGT)
chemotherapy	GH Research PLC (GHRS)
Chemotherapy	Amneal Pharmaceuticals, Inc. (AMRX)
Chemotherapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Chemotherapy	IGM Biosciences, Inc. (IGMS)
clobetasol	GH Research PLC (GHRS)
clostridium butyricum cbm 588 probiotic strain	GH Research PLC (GHRS)
Concurrent chemotherapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Crizotinib	BRISTOL MYERS SQUIBB CO (BMY)
dabrafenib	GH Research PLC (GHRS)
degarelix	GH Research PLC (GHRS)
degarelix	KYNTRA BIO INC. (KYNB)
derazantinib	ARQULE INC (ARQL)
disitamab vedotin	PFIZER INC (PFE)
Docetetaxel	Merck & Co., Inc. (MRK)
domvanalimab	GILEAD SCIENCES, INC. (GILD)
Enfortumab Vedotin	Merck & Co., Inc. (MRK)
Ensartinib	ENANTA PHARMACEUTICALS INC (ENTA)
Ensartinib	Merus N.V. (MRUS)
Erbitux®	FATE THERAPEUTICS INC (FATE)
Erbitux®	Amneal Pharmaceuticals, Inc. (AMRX)
Eribulin Mesylate	Arbutus Biopharma Corp (ABUS)
Erlotinib	Amneal Pharmaceuticals, Inc. (AMRX)
Erlotinib Hydrochloride	Amneal Pharmaceuticals, Inc. (AMRX)
Etoposide	ADMA BIOLOGICS, INC. (ADMA)
Evolocumab	UNITED THERAPEUTICS Corp (UTHR)
fdc fianlimab+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
ficerafusp alfa (formerly BCA101)	Bicara Therapeutics Inc. (BCAX)
ficlatuzumab	AVEO PHARMACEUTICALS, INC. (AVEO)
First-line Chemotherapy	Merus N.V. (MRUS)
flot chemotherapy	ASTRAZENECA PLC (AZN)
fludarabine	Filana Therapeutics Inc. (FLNA)
Flutamide	ARS Pharmaceuticals, Inc. (SPRY)
FOLFIRI	IGM Biosciences, Inc. (IGMS)
FOLFIRI + Zimberelimab + Domvanalimab	IGM Biosciences, Inc. (IGMS)
FOLFIRI or FOLFOX or Regorafenib	IGM Biosciences, Inc. (IGMS)
FOLFIRI-HD	IGM Biosciences, Inc. (IGMS)
FOLFIRI+cetuximab	IGM Biosciences, Inc. (IGMS)
Folfirinox	Tango Therapeutics, Inc. (TNGX)
FOLFIRINOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX	KYNTRA BIO INC. (KYNB)
FOLFOX neoadjuvant chemotherapy	Merus N.V. (MRUS)
FOLFOX-4	IGM Biosciences, Inc. (IGMS)
FOLFOX-7	IGM Biosciences, Inc. (IGMS)
folinic acid	Merus N.V. (MRUS)
Four week alternating FOLFOX and FOLFIRI	IGM Biosciences, Inc. (IGMS)
Fruquintinib	IGM Biosciences, Inc. (IGMS)
goserelin	KYNTRA BIO INC. (KYNB)
goserelin	GH Research PLC (GHRS)
goserelin	GH Research PLC (GHRS)
Goserelin acetate	KYNTRA BIO INC. (KYNB)
HER3-DXd	Merck & Co., Inc. (MRK)
histrelin acetate	KYNTRA BIO INC. (KYNB)
hmpl-453	HUTCHMED (China) Ltd (HMDCF)
Hormone Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
Hyperthermic Intraperitoneal Chemotherapy	Merus N.V. (MRUS)
I-DXd	Merck & Co., Inc. (MRK)
Ifosfamide	UNITED THERAPEUTICS Corp (UTHR)
ifx-2.0	TuHURA Biosciences, Inc./NV (HURA)
ifx2.0	TuHURA Biosciences, Inc./NV (HURA)
Immune Checkpoint Inhibitor	Merus N.V. (MRUS)
Immune induction therapy	Merus N.V. (MRUS)
Immune induction therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Immunomaintenance therapy	Crinetics Pharmaceuticals, Inc. (CRNX)
Intismeran autogene	Merus N.V. (MRUS)
Intismeran autogene	Merck & Co., Inc. (MRK)
intrathecal chemotherapy	GH Research PLC (GHRS)
intravenous administration of autologous	GH Research PLC (GHRS)
intravenous tislelizumab	BeOne Medicines Ltd. (ONC)
Intravenous Tislelizumab	Merus N.V. (MRUS)
Intravenous Tislelizumab	BeOne Medicines Ltd. (ONC)
Investigator's Choice	Merus N.V. (MRUS)
Investigator's selection of appropriate chemotherapy regimen	Merus N.V. (MRUS)
Ivosidenib	AGIOS PHARMACEUTICALS, INC. (AGIO)
Ivosidenib Oral Tablet	AGIOS PHARMACEUTICALS, INC. (AGIO)
l-leucovorin	Merus N.V. (MRUS)
Lagevrio	Merck & Co., Inc. (MRK)
lanreotide	GH Research PLC (GHRS)
lenvatinib	GH Research PLC (GHRS)
lenvatinib	BRISTOL MYERS SQUIBB CO (BMY)
Lenvatinib	ASTRAZENECA PLC (AZN)
Leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Amneal Pharmaceuticals, Inc. (AMRX)
Leucovorin Calcium	Merus N.V. (MRUS)
Leucovorin Calcium	Arcus Biosciences, Inc. (RCUS)
leucovorin calcium/levoleucovorin	GH Research PLC (GHRS)
Leucovorin/levofolinate calcium	Merck & Co., Inc. (MRK)
leuprolide	GH Research PLC (GHRS)
leuprolide	GH Research PLC (GHRS)
Leuprolide	KYNTRA BIO INC. (KYNB)
Leuprolide acetate	KYNTRA BIO INC. (KYNB)
Levoleucovorin	Merck & Co., Inc. (MRK)
Lymphodepleting chemotherapy	Merus N.V. (MRUS)
MEDI4736	ASTRAZENECA PLC (AZN)
MEDI4736+Tremelimumab	ASTRAZENECA PLC (AZN)
mFOLFIRINOX infusion	Tango Therapeutics, Inc. (TNGX)
milademetan	Rain Oncology Inc. (RAIN)
minocycline	GH Research PLC (GHRS)
Mitomycin	Merus N.V. (MRUS)
Mitomycin-C	Merus N.V. (MRUS)
MK-0482	Merck & Co., Inc. (MRK)
MK-3120	Merck & Co., Inc. (MRK)
MK-3475	Merck & Co., Inc. (MRK)
MK-4830	Merck & Co., Inc. (MRK)
Multikine	CEL SCI CORP (CVM)
nadofaragene firadenovec	VERTEX PHARMACEUTICALS INC / MA (VRTX)
Nadofaragene Firadenovec	Merus N.V. (MRUS)
nbtxr3	LianBio (LIANY)
neoadjuvant chemotherapy	GH Research PLC (GHRS)
Neoadjuvant olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
Neratinib	ENANTA PHARMACEUTICALS INC (ENTA)
New Formulation of Niraparib and Abiraterone Acetate	ARS Pharmaceuticals, Inc. (SPRY)
New Formulation of Niraparib and Abiraterone Acetate	Royalty Pharma plc (RPRX)
Nilutamide	ARS Pharmaceuticals, Inc. (SPRY)
Niraparib	ARS Pharmaceuticals, Inc. (SPRY)
nofazinlimab	EQRx, Inc. (EQRX)
nogapendekin alfa inbakicept	ImmunityBio, Inc. (IBRX)
Olaparib	Merck & Co., Inc. (MRK)
OP-1250	Olema Pharmaceuticals, Inc. (OLMA)
open-label azd9291 80 mg/40 mg	ASTRAZENECA PLC (AZN)
osimertinib	GH Research PLC (GHRS)
Osimertinib	Amneal Pharmaceuticals, Inc. (AMRX)
osimertinib 80 mg/40 mg	ASTRAZENECA PLC (AZN)
ozuriftamab vedotin	BioAtla, Inc. (BCAB)
Paltusotine	Crinetics Pharmaceuticals, Inc. (CRNX)
panitumumab	GH Research PLC (GHRS)
pazopanib	Incyte Corp. (INCY)
PCV20	Vaxcyte, Inc. (PCVX)
PCV21	Vaxcyte, Inc. (PCVX)
PD-1 inhibitor	Merus N.V. (MRUS)
pds0101	PDS Biotechnology Corp (PDSB)
Pemetrexed	ELI LILLY & Co (LLY)
Pemetrexed Disodium	ADMA BIOLOGICS, INC. (ADMA)
Pemetrexed Disodium	ENANTA PHARMACEUTICALS INC (ENTA)
pemigatinib	Incyte Corp. (INCY)
Pertuzumab	Filana Therapeutics Inc. (FLNA)
petosemtamab	Merus N.V. (MRUS)
Physician's choice chemotherapy	Merus N.V. (MRUS)
platinum based chemotherapy	GH Research PLC (GHRS)
plx-200	Polaryx Therapeutics Inc. (PLYX)
preoperative chemotherapy	GH Research PLC (GHRS)
Procarbazine Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Pumitamig	BRISTOL MYERS SQUIBB CO (BMY)
Pumitamig	BioNTech SE (BNTX)
ramucirumab	GH Research PLC (GHRS)
regn15505+cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
Regorafenib	UNITED THERAPEUTICS Corp (UTHR)
relacorilant	CORCEPT THERAPEUTICS INC (CORT)
Relugolix	Myovant Sciences Ltd. (MYOV)
Relugolix Combination Tablet	Myovant Sciences Ltd. (MYOV)
renovogem	RenovoRx, Inc. (RNXT)
Repotrectinib	BRISTOL MYERS SQUIBB CO (BMY)
Rescue medications for chemotherapy	Merus N.V. (MRUS)
rigosertib	TRAWS PHARMA, INC. (ONTX)
rocapuldencel-t	ARGOS THERAPEUTICS INC (ARGS)
rp1 in combination with nivolumab	Replimune Group, Inc. (REPL)
RPH-002	FATE THERAPEUTICS INC (FATE)
RPH-002	Amneal Pharmaceuticals, Inc. (AMRX)
Rucaparib camsylate	KYNTRA BIO INC. (KYNB)
ryz801	RayzeBio, Inc. (RYZB)
Sacituzumab Govitecan	Arbutus Biopharma Corp (ABUS)
savolitinib	ASTRAZENECA PLC (AZN)
Seasonal Influenza Vaccine	Vaxcyte, Inc. (PCVX)
Selpercatinib	ELI LILLY & Co (LLY)
Single-agent chemotherapy	Merus N.V. (MRUS)
Standard adjuvant chemotherapy	Merus N.V. (MRUS)
Sturlimogene Erparepvec	Replimune Group, Inc. (REPL)
subcutaneous tislelizumab	BeOne Medicines Ltd. (ONC)
Subcutaneous Tislelizumab	BeOne Medicines Ltd. (ONC)
Subcutaneous Tislelizumab	Merus N.V. (MRUS)
sugemalimab	EQRx, Inc. (EQRX)
sul-dur	Entasis Therapeutics Holdings Inc. (ETTX)
supportive care	GH Research PLC (GHRS)
Supportive care measures	Merck & Co., Inc. (MRK)
tak-676	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
tak-788	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
Tarlatamab	IGM Biosciences, Inc. (IGMS)
Tarlatamab	REGENXBIO Inc. (RGNX)
Tarlatamab	Merus N.V. (MRUS)
Telisotuzumab Adizutecan	AbbVie Inc. (ABBV)
Temozolomide	IGM Biosciences, Inc. (IGMS)
tepotinib	GH Research PLC (GHRS)
timing to initiate the adjuvant FOLFOX chemotherapy	Merus N.V. (MRUS)
tivozanib	AVEO PHARMACEUTICALS, INC. (AVEO)
Tivozanib	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
Topotecan	Merus N.V. (MRUS)
Toripalimab	Crinetics Pharmaceuticals, Inc. (CRNX)
TP regimen	Merus N.V. (MRUS)
tpst-1120	Tempest Therapeutics, Inc. (TPST)
trametinib	GH Research PLC (GHRS)
trametinib dimethyl sulf	GH Research PLC (GHRS)
tremelimumab	CG Oncology, Inc. (CGON)
Tremelimumab	ASTRAZENECA PLC (AZN)
triptorelin	GH Research PLC (GHRS)
triptorelin	GH Research PLC (GHRS)
truseltiq	BridgeBio Pharma, Inc. (BBIO)
Tucatinib	PFIZER INC (PFE)
ugn-104	UroGen Pharma Ltd. (URGN)
vax-31	Vaxcyte, Inc. (PCVX)
venetoclax 10 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 100 mg oral tablet [venclexta]	GH Research PLC (GHRS)
venetoclax 50 mg oral tablet [venclexta]	GH Research PLC (GHRS)
Vepugratinib	ELI LILLY & Co (LLY)
Vibostolimab	Merck & Co., Inc. (MRK)
Vinblastine	ASTRAZENECA PLC (AZN)
vinorelbine	MAIA Biotechnology, Inc. (MAIA)
Vudalimab	KYNTRA BIO INC. (KYNB)
zanidatamab	GH Research PLC (GHRS)
Zanidatamab	Merus N.V. (MRUS)
zanzalintinib	EXELIXIS, INC. (EXEL)
Zanzalintinib	Merck & Co., Inc. (MRK)
zimberelimab	GILEAD SCIENCES, INC. (GILD)
zolbetuximab	Merus N.V. (MRUS)

Phase 2(262)

Drug	Company
[177Lu]Lu-DOTATATE	Novartis AG (NVS)
0.5 ml dose of 1.1 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 ml dose of 2.2 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 ml dose of 2.2/4.4 mcg VAX-24	Vaxcyte, Inc. (PCVX)
0.5 mL dose of PCV20	Vaxcyte, Inc. (PCVX)
0.5 mL of the High-PFS dose VAX-31	Vaxcyte, Inc. (PCVX)
0.5 mL of the mid dose VAX-31	Vaxcyte, Inc. (PCVX)
5 FU bolus	IGM Biosciences, Inc. (IGMS)
5 FU continuous	IGM Biosciences, Inc. (IGMS)
6-thio-2'-deoxyguanosine	MAIA Biotechnology, Inc. (MAIA)
9MW2821	Crinetics Pharmaceuticals, Inc. (CRNX)
abc294640	RedHill Biopharma Ltd. (RDHL)
ABT-869	AbbVie Inc. (ABBV)
ACR-368	Acrivon Therapeutics, Inc. (ACRV)
Adavosertib	ADMA BIOLOGICS, INC. (ADMA)
Adenovirus 5 CEA/MUC1/Brachyury Vaccine Tri-Ad5	CG Oncology, Inc. (CGON)
ADX-631	Aldeyra Therapeutics, Inc. (ALDX)
AG-120	AGIOS PHARMACEUTICALS, INC. (AGIO)
ALLO-316	Allogene Therapeutics, Inc. (ALLO)
ALLO-647	Allogene Therapeutics, Inc. (ALLO)
ALN-BCAT	ALNYLAM PHARMACEUTICALS, INC. (ALNY)
Amivantamab	Structure Therapeutics Inc. (GPCR)
Amivantamab and Recombinant Human Hyaluronidase	Structure Therapeutics Inc. (GPCR)
Amivantamab and Recombinant Human Hyaluronidase	FATE THERAPEUTICS INC (FATE)
Amivantamab IV	Bausch Health Companies Inc. (BHC)
Amivantamab IV	Structure Therapeutics Inc. (GPCR)
Amivantamab SC	Bausch Health Companies Inc. (BHC)
Amivantamab SC	Structure Therapeutics Inc. (GPCR)
anlotinib	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
Anti-GPC3-CAR Autologous T Lymphocytes	Filana Therapeutics Inc. (FLNA)
Antiandrogen Therapy	ARS Pharmaceuticals, Inc. (SPRY)
Antiandrogen Therapy	Janux Therapeutics, Inc. (JANX)
Antiandrogen Therapy	Myovant Sciences Ltd. (MYOV)
Antiandrogen Therapy	Royalty Pharma plc (RPRX)
ARCT-154 Self-Amplifying RNA SARS-CoV-2 Vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
Arginine hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Arm A - Olaparib	IGM Biosciences, Inc. (IGMS)
Astra Zeneca COVID-19 vaccine	Arcturus Therapeutics Holdings Inc. (ARCT)
Autogene cevumeran	Merus N.V. (MRUS)
Autogene cevumeran	Tango Therapeutics, Inc. (TNGX)
Avelumab	NEKTAR THERAPEUTICS (NKTR)
Avelumab	Structure Therapeutics Inc. (GPCR)
AZD6738	Merus N.V. (MRUS)
balstililmab	AGENUS INC (AGEN)
BET Bromodomain Inhibitor ZEN-3694	KYNTRA BIO INC. (KYNB)
Binimetinib	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Boserolimab	Merus N.V. (MRUS)
Boserolimab	Merck & Co., Inc. (MRK)
Botensilimab	ENANTA PHARMACEUTICALS INC (ENTA)
Branched-Chain Amino Acids	ENANTA PHARMACEUTICALS INC (ENTA)
BXCL701	Merck & Co., Inc. (MRK)
BXCL701	BioXcel Therapeutics, Inc. (BTAI)
cabozantinib	CG Oncology, Inc. (CGON)
Cabozantinib	ENANTA PHARMACEUTICALS INC (ENTA)
Cabozantinib	UNITED THERAPEUTICS Corp (UTHR)
Cabozantinib S-malate	ENANTA PHARMACEUTICALS INC (ENTA)
casdozokitug	Coherus Oncology, Inc. (CHRS)
cemiplimab	MAIA Biotechnology, Inc. (MAIA)
cemiplimab	West Pharmaceutical Services Inc. (WST)
cemiplimab	Replimune Group, Inc. (REPL)
Cemiplimab	Royalty Pharma plc (RPRX)
Cemiplimab	ELI LILLY & Co (LLY)
Cemiplimab	Assertio Holdings, Inc. (ASRT)
Cemiplimab	ADMA BIOLOGICS, INC. (ADMA)
Cemiplimab	Merus N.V. (MRUS)
Cemiplimab	FATE THERAPEUTICS INC (FATE)
Cemiplimab 350 mg IV	Merus N.V. (MRUS)
ceralasertib	GH Research PLC (GHRS)
certepetide	LISATA THERAPEUTICS, INC. (LSTA)
cetuximab	Verastem, Inc. (VSTM)
Cetuximab	Structure Therapeutics Inc. (GPCR)
Cetuximab	ADMA BIOLOGICS, INC. (ADMA)
Chemotherapeutic Agent	Merus N.V. (MRUS)
chlorhexidine	GH Research PLC (GHRS)
clindamycin	GH Research PLC (GHRS)
Clobetasol	Bausch Health Companies Inc. (BHC)
Clobetasol Propionate	UNITED THERAPEUTICS Corp (UTHR)
cmp-001	CHECKMATE PHARMACEUTICALS, INC. (CMPI)
concurrent chemo/radiation therapy	JOHNSON & JOHNSON (JNJ)
concurrent chemo/radiation therapy	Innovation Pharmaceuticals Inc. (IPIX)
Copanlisib Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Crizotinib	Amneal Pharmaceuticals, Inc. (AMRX)
CTLA-4 Antibody	Crinetics Pharmaceuticals, Inc. (CRNX)
Cyclophophamide	Allogene Therapeutics, Inc. (ALLO)
cylembio	IO Biotech, Inc. (IOBT)
dabogratinib	Tyra Biosciences, Inc. (TYRA)
Dabogratinib TBD	Tyra Biosciences, Inc. (TYRA)
Defactinib Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Degarelix	ARS Pharmaceuticals, Inc. (SPRY)
Diclofenac Potassium	ENANTA PHARMACEUTICALS INC (ENTA)
direct oral anticoagulant	GH Research PLC (GHRS)
DOMVANALIMAB	IGM Biosciences, Inc. (IGMS)
Dostarlimab	IGM Biosciences, Inc. (IGMS)
Dostarlimab	Merus N.V. (MRUS)
Doxycycline	Bausch Health Companies Inc. (BHC)
Eflornithine Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
enmd-2076	CASI Pharmaceuticals, Inc. (CASIF)
Ensartinib	ADMA BIOLOGICS, INC. (ADMA)
EOS-448	iTeos Therapeutics, Inc. (ITOS)
erlotinib	CG Oncology, Inc. (CGON)
Erlotinib	ADMA BIOLOGICS, INC. (ADMA)
etrumadenant	Arcus Biosciences, Inc. (RCUS)
fdc fianlimab+cemiplimab	West Pharmaceutical Services Inc. (WST)
Fianlimab	ADMA BIOLOGICS, INC. (ADMA)
FID-007	Fulgent Genetics Inc. (FLGT)
FID007	Fulgent Genetics Inc. (FLGT)
Filgrastim	Replimune Group, Inc. (REPL)
FLOT	Arcus Biosciences, Inc. (RCUS)
Fludarabine	Allogene Therapeutics, Inc. (ALLO)
folfox regimen	LISATA THERAPEUTICS, INC. (LSTA)
FOLFOX regimen	KYNTRA BIO INC. (KYNB)
FOLFOX regimen	IGM Biosciences, Inc. (IGMS)
gedeptin	GeoVax Labs, Inc. (GOVX)
Gemzar	Zentalis Pharmaceuticals, Inc. (ZNTL)
Goserelin	ENANTA PHARMACEUTICALS INC (ENTA)
Goserelin Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Goserelin Acetate	Royalty Pharma plc (RPRX)
GSK5764227	Merus N.V. (MRUS)
had5-hpv vaccine	ImmunityBio, Inc. (IBRX)
HER3-DXd	Merus N.V. (MRUS)
High-dose Anakinra	ENANTA PHARMACEUTICALS INC (ENTA)
Histrelin	KYNTRA BIO INC. (KYNB)
HRS-4642+AG+Nimotuzumab	Merus N.V. (MRUS)
IM96 CAR-T Cells	Merus N.V. (MRUS)
Immune checkpoint inhibitor	KYNTRA BIO INC. (KYNB)
increase dose of tocilizumab	Merus N.V. (MRUS)
ino-3112	INOVIO PHARMACEUTICALS, INC. (INO)
ino-5401	INOVIO PHARMACEUTICALS, INC. (INO)
ITI-1549	Intra-Cellular Therapies, Inc. (ITCI)
Ivonescimab	IGM Biosciences, Inc. (IGMS)
JNJ-90301900	Merus N.V. (MRUS)
Lazertinib	Bausch Health Companies Inc. (BHC)
Lazertinib	Structure Therapeutics Inc. (GPCR)
lenvatinib	CG Oncology, Inc. (CGON)
Lenvatinib	ENANTA PHARMACEUTICALS INC (ENTA)
Lenvatinib	UNITED THERAPEUTICS Corp (UTHR)
Lenvatinib Mesylate	UNITED THERAPEUTICS Corp (UTHR)
Leronlimab	CytoDyn Inc. (CYDY)
leucovorin	BeOne Medicines Ltd. (ONC)
Leucovorin	Jazz Pharmaceuticals plc (JAZZ)
Leucovorin	UNITED THERAPEUTICS Corp (UTHR)
Leucovorin	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Leucovorin	AbbVie Inc. (ABBV)
Leucovorin Calcium	BridgeBio Oncology Therapeutics, Inc. (BBOT)
Leuprolide	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	ARS Pharmaceuticals, Inc. (SPRY)
Leuprolide Acetate	ENANTA PHARMACEUTICALS INC (ENTA)
Leuprolide Acetate	Royalty Pharma plc (RPRX)
Levoleucovorin Calcium	UNITED THERAPEUTICS Corp (UTHR)
ln-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LN-145	ENANTA PHARMACEUTICALS INC (ENTA)
LN-145	Merus N.V. (MRUS)
LN-145	Filana Therapeutics Inc. (FLNA)
Long-acting leronlimab	CytoDyn Inc. (CYDY)
Low-dose Anakinra	ENANTA PHARMACEUTICALS INC (ENTA)
lp-300	Lantern Pharma Inc. (LTRN)
lsta1	LISATA THERAPEUTICS, INC. (LSTA)
Lurbinectedin	Jazz Pharmaceuticals plc (JAZZ)
Lutetium Lu 177 Vipivotide Tetraxetan	KYNTRA BIO INC. (KYNB)
m6223	GH Research PLC (GHRS)
M6223	NEKTAR THERAPEUTICS (NKTR)
Maximum Tolerated Dose of leronlimab	CytoDyn Inc. (CYDY)
Methoxyamine	ADMA BIOLOGICS, INC. (ADMA)
Methoxyamine	Merus N.V. (MRUS)
Methoxyamine	ENANTA PHARMACEUTICALS INC (ENTA)
mFOLFIRINOX	BioNTech SE (BNTX)
mFOLFOX	Jazz Pharmaceuticals plc (JAZZ)
mFOLFOX/FOLFIRI	KYNTRA BIO INC. (KYNB)
Mitomycin	ENANTA PHARMACEUTICALS INC (ENTA)
Mitomycin C	ENANTA PHARMACEUTICALS INC (ENTA)
Montanide ISA 51 VG	ENANTA PHARMACEUTICALS INC (ENTA)
Montanide ISA 51 VG	Filana Therapeutics Inc. (FLNA)
montelukast	GH Research PLC (GHRS)
Neratinib	Filana Therapeutics Inc. (FLNA)
Nilotinib Hydrochloride Monohydrate	ENANTA PHARMACEUTICALS INC (ENTA)
Niraparib	Royalty Pharma plc (RPRX)
Niraparib	IGM Biosciences, Inc. (IGMS)
nis793	Novartis AG (NVS)
nktr-255	GH Research PLC (GHRS)
Nogapendekin Alfa	CG Oncology, Inc. (CGON)
nuzefatide pevedotin	BICYCLE THERAPEUTICS PLC (BCYC)
Olaparib	Crinetics Pharmaceuticals, Inc. (CRNX)
Olaparib	ADMA BIOLOGICS, INC. (ADMA)
Olaparib	ENANTA PHARMACEUTICALS INC (ENTA)
OSE2101	IGM Biosciences, Inc. (IGMS)
ot-101	Oncotelic Therapeutics, Inc. (OTLC)
part 1	Verrica Pharmaceuticals Inc. (VRCA)
part 2	Verrica Pharmaceuticals Inc. (VRCA)
PD-1antibody plus GEMOX	Merus N.V. (MRUS)
Pegfilgrastim	Assertio Holdings, Inc. (ASRT)
Pegfilgrastim	Replimune Group, Inc. (REPL)
Pemetrexed	Amneal Pharmaceuticals, Inc. (AMRX)
PF-08634404	Merus N.V. (MRUS)
platinum compound	GH Research PLC (GHRS)
propranolol	GH Research PLC (GHRS)
Propranolol	Bausch Health Companies Inc. (BHC)
Propranolol Hydrochloride	ENANTA PHARMACEUTICALS INC (ENTA)
Propranolol Hydrochloride	UNITED THERAPEUTICS Corp (UTHR)
QL1706	ENANTA PHARMACEUTICALS INC (ENTA)
Raludotatug Deruxtecan	Merck & Co., Inc. (MRK)
ramucirumab	Sanofi (SNY)
Ramucirumab	Jazz Pharmaceuticals plc (JAZZ)
Randomized	Crinetics Pharmaceuticals, Inc. (CRNX)
Recombinant human tissue kallikrein	Merus N.V. (MRUS)
Relatlimab	ENANTA PHARMACEUTICALS INC (ENTA)
Relugolix	ENANTA PHARMACEUTICALS INC (ENTA)
Relugolix	KYNTRA BIO INC. (KYNB)
Rencofilstat (formerly CRV431; CPI-431-32)	Hepion Pharmaceuticals, Inc. (CTRVP)
rencofilstat (formerly CRV431)	Hepion Pharmaceuticals, Inc. (CTRVP)
rp1	Replimune Group, Inc. (REPL)
RP2 Monotherapy	Replimune Group, Inc. (REPL)
rtx-224	Rubius Therapeutics, Inc. (RUBY)
sacituzumab govitecan	GH Research PLC (GHRS)
Sacituzumab Govitecan	FATE THERAPEUTICS INC (FATE)
Sacituzumab Govitecan	NEKTAR THERAPEUTICS (NKTR)
sar444245	Sanofi (SNY)
Sargramostim	Filana Therapeutics Inc. (FLNA)
saruparib	GH Research PLC (GHRS)
Serplulimab	ENANTA PHARMACEUTICALS INC (ENTA)
Setanaxib	Calliditas Therapeutics AB (CALT)
si-b001	NYMOX PHARMACEUTICAL CORP (NYMXF)
srf388	Coherus Oncology, Inc. (CHRS)
suba-itraconazole bccns	Inhibitor Therapeutics, Inc. (INTI)
SVN53-67/M57-KLH Peptide Vaccine	Filana Therapeutics Inc. (FLNA)
tas-120	CG Oncology, Inc. (CGON)
timolol	GH Research PLC (GHRS)
Timolol	Bausch Health Companies Inc. (BHC)
Tivozanib	Replimune Group, Inc. (REPL)
Tocilizumab	Arcus Biosciences, Inc. (RCUS)
tqb2618	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tqb2618 injection; penpulimab	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tqb3616	SPRING PHARMACEUTICAL GROUP, INC. (CYIG)
tremelimumab	AC Immune SA (ACIU)
triptorelin	KYNTRA BIO INC. (KYNB)
tti-101	Tvardi Therapeutics, Inc. (TVRD)
Tucatinib	Merus N.V. (MRUS)
tusamitamab ravtansine	Sanofi (SNY)
TYRA-300	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.125 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.25 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.375 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-300 0.50 mg/kg	Tyra Biosciences, Inc. (TYRA)
TYRA-430	Tyra Biosciences, Inc. (TYRA)
ubamatamab	REGENERON PHARMACEUTICALS, INC. (REGN)
Valemetostat Tosylate	KYNTRA BIO INC. (KYNB)
vax-24	Vaxcyte, Inc. (PCVX)
vcn-01	Theriva Biologics, Inc. (TOVX)
Veliparib	IGM Biosciences, Inc. (IGMS)
versamune hpv	PDS Biotechnology Corp (PDSB)
vg2025	IO Biotech, Inc. (IOBT)
vidutolimod	CHECKMATE PHARMACEUTICALS, INC. (CMPI)
vidutolimod	REGENERON PHARMACEUTICALS, INC. (REGN)
Vinblastine Sulfate	Assertio Holdings, Inc. (ASRT)
vobramitamab duocarmazine	MACROGENICS INC (MGNX)
Vobramitamab Duocarmazine (vobra duo)	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.0 mg	MACROGENICS INC (MGNX)
vobramitamab duocarmazine 2.7 mg	MACROGENICS INC (MGNX)
vp-315	Verrica Pharmaceuticals Inc. (VRCA)
vs-7375	Verastem, Inc. (VSTM)
Zentalis	Zentalis Pharmaceuticals, Inc. (ZNTL)
ZIMBERELIMAB	IGM Biosciences, Inc. (IGMS)
zinc gluconate	GH Research PLC (GHRS)

Phase 1(190)

Drug	Company
[177lu]lu-nns309	Novartis AG (NVS)
[225ac]ac-aky-1189	Aktis Oncology Inc. (AKTS)
[64cu]cu-aky-1189	Aktis Oncology Inc. (AKTS)
[68ga]ga-nns309	Novartis AG (NVS)
[ga-68]-pnt6555	ELI LILLY & Co (LLY)
[lu-177]-pnt6555	ELI LILLY & Co (LLY)
111in-etn029	NOVARTIS AG (NVSEF)
111in-etn029	Novartis AG (NVS)
177lu-dfc413	Novartis AG (NVS)
18F-NOTA-ABY-030	Amneal Pharmaceuticals, Inc. (AMRX)
18F-NOTA-ABY-030	FATE THERAPEUTICS INC (FATE)
225ac-etn029	NOVARTIS AG (NVSEF)
225ac-etn029	Novartis AG (NVS)
5-FU	Xencor Inc (XNCR)
68ga-dfc413	Novartis AG (NVS)
68ga-nns309	Novartis AG (NVS)
AB521	EXELIXIS, INC. (EXEL)
Abiraterone acetate	Royalty Pharma plc (RPRX)
Adebrelimab	Merus N.V. (MRUS)
ADI-270	Adicet Bio, Inc. (ACET)
afp-tcr-t	CELLULAR BIOMEDICINE GROUP, INC. (CMBG)
aldesleukin	GH Research PLC (GHRS)
alpha-lactalbumin breast cancer vaccine	Anixa Biosciences Inc (ANIX)
Aminolevulinic Acid	ENANTA PHARMACEUTICALS INC (ENTA)
amivantamab	GH Research PLC (GHRS)
amivantamab	GH Research PLC (GHRS)
Androgen Deprivation Therapy	Janux Therapeutics, Inc. (JANX)
Anetumab Ravtansine	ENANTA PHARMACEUTICALS INC (ENTA)
anti-pd-1	TriSalus Life Sciences Inc. (TLSI)
Anti-STEAP1 CAR T-cells	KYNTRA BIO INC. (KYNB)
APR-1051	Aprea Therapeutics, Inc. (APRE)
ARO-HIF2	ARROWHEAD PHARMACEUTICALS, INC. (ARWR)
arx305	Ambrx Biopharma Cayman, Inc. (AMAM)
ASP2138	Tango Therapeutics, Inc. (TNGX)
ASP2138	Xencor Inc (XNCR)
ASP2138	ENANTA PHARMACEUTICALS INC (ENTA)
ASP2138	Merus N.V. (MRUS)
ATG-022	Merck & Co., Inc. (MRK)
autologous genetically modified mage a10ᶜ⁷⁹⁶t cells	Adaptimmune Therapeutics PLC (ADAP)
Avelumab	Accustem Sciences Inc. (ACUT)
axn-27m/imm27m	Instil Bio, Inc. (TIL)
azenosertib	Zentalis Pharmaceuticals, Inc. (ZNTL)
ba3182	BioAtla, Inc. (BCAB)
BA3182 (CAB-EpCAM x CAB-CD3)	BioAtla, Inc. (BCAB)
Balstilimab	AGENUS INC (AGEN)
Berzosertib	Merus N.V. (MRUS)
BET Bromodomain Inhibitor ZEN-3694	FATE THERAPEUTICS INC (FATE)
bgb-b2033	BeOne Medicines Ltd. (BEIGF)
bgb-b2033	BeOne Medicines Ltd. (ONC)
BI 764532	Merus N.V. (MRUS)
BI 770371	Amneal Pharmaceuticals, Inc. (AMRX)
BI 770371	FATE THERAPEUTICS INC (FATE)
Birinapant	IGM Biosciences, Inc. (IGMS)
Botensilimab	AGENUS INC (AGEN)
Breast cancer vaccine (α-lactalbumin)	Anixa Biosciences Inc (ANIX)
Budigalimab	AbbVie Inc. (ABBV)
c-scape	Achaogen, Inc. (AKAO)
Cabozantinib	Arcus Biosciences, Inc. (RCUS)
Capmatinib	Structure Therapeutics Inc. (GPCR)
CAPOX	Merck & Co., Inc. (MRK)
Casdatifan	Arcus Biosciences, Inc. (RCUS)
cemiplimab	REGENERON PHARMACEUTICALS, INC. (REGN)
Cemiplimab	Crinetics Pharmaceuticals, Inc. (CRNX)
cetrelimab	JOHNSON & JOHNSON (JNJ)
cetrelimab	Innovation Pharmaceuticals Inc. (IPIX)
Cetuximab	NEKTAR THERAPEUTICS (NKTR)
cg0070	GH Research PLC (GHRS)
CIML NK cell Infusion	Amneal Pharmaceuticals, Inc. (AMRX)
CIML NK cell Infusion	FATE THERAPEUTICS INC (FATE)
CLD-201 (SuperNova™ / SNV1)	Calidi Biotherapeutics Inc. (CLDI)
cosibelimab	Checkpoint Therapeutics, Inc. (CKPT)
Crizotinib	ENANTA PHARMACEUTICALS INC (ENTA)
dcc-2812	Deciphera Pharmaceuticals, Inc. (DCPH)
dff332	Novartis AG (NVS)
dff332	NOVARTIS AG (NVSEF)
Domvanalimab	Arcus Biosciences, Inc. (RCUS)
EB-SELECT Single-Target CAR-NK Cells	Merus N.V. (MRUS)
Emavusertib	Amneal Pharmaceuticals, Inc. (AMRX)
emi-le	Day One Biopharmaceuticals, Inc. (DAWN)
emi-le	Mersana Therapeutics, Inc. (MRSN)
Encorafenib	FATE THERAPEUTICS INC (FATE)
Enfortumab Vedotin	ImmunityBio, Inc. (IBRX)
Entinostat	Syndax Pharmaceuticals Inc (SNDX)
Enzalutamide	Filana Therapeutics Inc. (FLNA)
epacadostat	Incyte Corp. (INCY)
Etoposide	Merus N.V. (MRUS)
Fludarabine	KYNTRA BIO INC. (KYNB)
gen-011	GENOCEA BIOSCIENCES, INC. (GNCA)
gl-onc1	GENELUX Corp (GNLX)
hmpl-453	HUTCHMED (China) Limited (HCM)
honokiol	GH Research PLC (GHRS)
Iadademstat	ENANTA PHARMACEUTICALS INC (ENTA)
IBRX-042	ImmunityBio, Inc. (IBRX)
IDE034	IDEAYA Biosciences, Inc. (IDYA)
IDE397	IDEAYA Biosciences, Inc. (IDYA)
IDE892	IDEAYA Biosciences, Inc. (IDYA)
ifx-hu2.0	Tyra Biosciences, Inc. (TYRA)
ifx-hu2.0	TuHURA Biosciences, Inc./NV (HURA)
incb062079	Incyte Corp. (INCY)
incb099280	Incyte Corp. (INCY)
Interleukin-15 Superagonist	FATE THERAPEUTICS INC (FATE)
Interleukin-15 Superagonist	Amneal Pharmaceuticals, Inc. (AMRX)
Ivosidenib	ENANTA PHARMACEUTICALS INC (ENTA)
jnj-86974680	JOHNSON & JOHNSON (JNJ)
jnj-86974680	Innovation Pharmaceuticals Inc. (IPIX)
JNJ-86974680	Janux Therapeutics, Inc. (JANX)
jnj-90301900	Innovation Pharmaceuticals Inc. (IPIX)
jnj-90301900	JOHNSON & JOHNSON (JNJ)
JSB462 Dose 1 QD	Merus N.V. (MRUS)
JSB462 Dose 2 QD	Merus N.V. (MRUS)
ko-2806	Kura Oncology, Inc. (KURA)
lazertinib	GH Research PLC (GHRS)
leucovorin	PFIZER INC (PFE)
leucovorin	ELI LILLY & Co (LLY)
Leucovorin	Arcus Biosciences, Inc. (RCUS)
Leucovorin	Xencor Inc (XNCR)
LN-145	IOVANCE BIOTHERAPEUTICS, INC. (IOVA)
LUNAR-FLU (seasonal influenza candidate)	Arcturus Therapeutics Holdings Inc. (ARCT)
LUNAR-H5N1	Arcturus Therapeutics Holdings Inc. (ARCT)
ly3410738	ELI LILLY & Co (LLY)
ly3962673	ELI LILLY & Co (LLY)
ly4066434	ELI LILLY & Co (LLY)
LY4175408	ELI LILLY & Co (LLY)
mFOLFIRINOX	Aclaris Therapeutics, Inc. (ACRS)
MK-0482	Merus N.V. (MRUS)
MK-4830	Merus N.V. (MRUS)
Monoclonal antibody BAT6026	Crinetics Pharmaceuticals, Inc. (CRNX)
Muzastotug	IGM Biosciences, Inc. (IGMS)
mvt-1075	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
mvt-2163	MABVAX THERAPEUTICS HOLDINGS, INC. (MBVX)
nana-val	Viracta Therapeutics, Inc. (VIRX)
nelitolimod	TriSalus Life Sciences Inc. (TLSI)
nir178	NOVARTIS AG (NVSEF)
nir178	Novartis AG (NVS)
NKTR-0165	NEKTAR THERAPEUTICS (NKTR)
NKTR-255	NEKTAR THERAPEUTICS (NKTR)
NKTR-288	NEKTAR THERAPEUTICS (NKTR)
NKTR-422	NEKTAR THERAPEUTICS (NKTR)
NP137	ENANTA PHARMACEUTICALS INC (ENTA)
Olomorasib	ELI LILLY & Co (LLY)
ONT01	ENANTA PHARMACEUTICALS INC (ENTA)
pdr001	NOVARTIS AG (NVSEF)
pdr001	Novartis AG (NVS)
Pemetrexed	ADMA BIOLOGICS, INC. (ADMA)
Peposertib	Accustem Sciences Inc. (ACUT)
pf-07934040	PFIZER INC (PFE)
pf-08046054	PFIZER INC (PFE)
pf-08052666	PFIZER INC (PFE)
ph-762	Phio Pharmaceuticals Corp. (PHIO)
Photodynamic Therapy	ENANTA PHARMACEUTICALS INC (ENTA)
Pidnarulex	Crinetics Pharmaceuticals, Inc. (CRNX)
Pneumococcal 13-valent Conjugate Vaccine	Amneal Pharmaceuticals, Inc. (AMRX)
Polymer-conjugated IL-15 Receptor Agonist NKTR-255	NEKTAR THERAPEUTICS (NKTR)
PTM-101	Merus N.V. (MRUS)
QEQ278	Novartis AG (NVS)
Quemliclustat	Arcus Biosciences, Inc. (RCUS)
rad001	Novartis AG (NVS)
rad001	NOVARTIS AG (NVSEF)
Ramucirumab	Xencor Inc (XNCR)
Ramucirumab	Tango Therapeutics, Inc. (TNGX)
retifanlimab	Incyte Corp. (INCY)
RP2	Replimune Group, Inc. (REPL)
RP3	Replimune Group, Inc. (REPL)
Sapanisertib	Royalty Pharma plc (RPRX)
Sapanisertib	Merus N.V. (MRUS)
sd-101	TriSalus Life Sciences Inc. (TLSI)
sigvotatug vedotin	PFIZER INC (PFE)
sl-279252	Shattuck Labs, Inc. (STTK)
sn301a	Senti Biosciences, Inc. (SNTI)
srf388	Surface Oncology, Inc. (SURF)
STRO-004	SUTRO BIOPHARMA, INC. (STRO)
Sulbactam 20mg/kg-Durlobactam 20mg/kg	Innoviva, Inc. (INVA)
Sulbactam 25mg/kg -Durlobactam 25mg/kg	Innoviva, Inc. (INVA)
tagmokitug	Coherus Oncology, Inc. (CHRS)
tak-676	TAKEDA PHARMACEUTICAL CO LTD (TKPHF)
tbio-4101	GH Research PLC (GHRS)
Testosterone Cypionate	ENANTA PHARMACEUTICALS INC (ENTA)
Testosterone Cypionate	Royalty Pharma plc (RPRX)
Therapeutic Autologous Dendritic Cells	Amneal Pharmaceuticals, Inc. (AMRX)
tislelizumab	BeOne Medicines Ltd. (ONC)
toripalimab	Coherus Oncology, Inc. (CHRS)
tp-6076	TETRAPHASE PHARMACEUTICALS INC (TTPH)
Vibostolimab	Merus N.V. (MRUS)
XmAb819	Xencor Inc (XNCR)
Zavedos®	Merus N.V. (MRUS)
Zimberelimab	Arcus Biosciences, Inc. (RCUS)
Zunsemetinib	Tango Therapeutics, Inc. (TNGX)
Zunsemetinib	KYNTRA BIO INC. (KYNB)
Zunsemetinib	Merus N.V. (MRUS)
zw251	Zymeworks Inc. (ZYME)

Preclinical(26)

Drug	Company
amooranin	ENZYMEBIOSYSTEMS (ENZB)
anti-caix	Checkpoint Therapeutics, Inc. (CKPT)
anti-caix antibody	Checkpoint Therapeutics, Inc. (CKPT)
anti-il-1a antibody	XBiotech Inc. (XBIT)
AR-401	Aridis Pharmaceuticals, Inc. (ARDS)
be-smart	ProPhase Labs, Inc. (PRPH)
etp	Greater Cannabis Company, Inc. (GCAN)
gtb-5550	GT Biopharma, Inc. (GTBP)
io112	IO Biotech, Inc. (IOBT)
iv rhdnase i	Xenetic Biosciences, Inc. (XBIO)
kur-503	Athenex, Inc. (ATNX)
mipsagargin	REBUS HOLDINGS, INC. (NSPX)
Moderna development candidate - GPC3	Carisma Therapeutics Inc. (CARM)
nano-mupirocin	Revium Rx. (RVRC)
neo-stc-01	Neon Therapeutics, Inc. (NTGN)
nktr-0166	NEKTAR THERAPEUTICS (NKTR)
oncr-021	Oncorus, Inc. (ONCR)
Ovarian cancer vaccine (AMHR2-ED)	Anixa Biosciences Inc (ANIX)
prx-asl	PHASERX, INC. (PZRX)
prx-ass1	PHASERX, INC. (PZRX)
siRNA targeting Beta2-spectrin	Bullfrog AI Holdings Inc. (BFRG)
spk-tpp1	Spark Therapeutics, Inc. (SPARK)
sw-3431	SpringWorks Therapeutics, Inc. (SWTX)
VPS4A inhibitors (novel series)	Calithera Biosciences, Inc. (CALA)
x.msc	VITASPRING BIOMEDICAL CO. LTD. (NONE)
zofin	Zeo ScientifiX, Inc. (ZEOX)

Unknown(16)

Drug	Company
ADXS-NEO	Ayala Pharmaceuticals, Inc. (ADXS)
AviPure dsRNA Clear	REPLIGEN CORP (RGEN)
bengay heat therapy	JOHNSON & JOHNSON (JNJ)
cabozantinib	Takeda Pharmaceutical Company Limited American Depositary Shares (each representing 1/2 of a share of Common Stock) (TAK)
cerliponase alfa	BIOMARIN PHARMACEUTICAL INC (BMRN)
Clarithromycin (sold under Klacid™, Claribid™, Klaricid™)	ABBOTT LABORATORIES (ABT)
Dried cannabis flower	CANNAPHARMARX, INC. (CPMD)
Full RNA sequencing workflow	Twist Bioscience Corp (TWST)
neutrogena light therapy aging mask+	JOHNSON & JOHNSON (JNJ)
not specified	ONCOLYTICS BIOTECH INC (ONCY)
OPUS Pre-Packed Columns	REPLIGEN CORP (RGEN)
SoHum Living Soil™	American Cannabis Company, Inc. (AMMJ)
stride	ASTRAZENECA PLC (AZN)
TangenX SC Device	REPLIGEN CORP (RGEN)
Vaxneuvance	Merck & Co., Inc. (MRK)
vigiv	Emergent BioSolutions Inc. (EBS)

N/A(5)

Drug	Company
Crizotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
Erlotinib	Crinetics Pharmaceuticals, Inc. (CRNX)
First-line antihypertensive single-pill combination	Merus N.V. (MRUS)
Pemetrexed Disodium	Amneal Pharmaceuticals, Inc. (AMRX)
Pemetrexed Disodium	Crinetics Pharmaceuticals, Inc. (CRNX)

Phase 1/Phase 2(31)

Drug	Company
[203pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
[212pb]pb-mp0712	MOLECULAR PARTNERS AG (MOLN)
[212pb]pb-psv359	Perspective Therapeutics, Inc. (CATX)
20 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
31 valent pneumococcal conjugate vaccine	Vaxcyte, Inc. (PCVX)
avelumab	VACCINEX, INC. (VCNX)
azd9793 intravenous monotherapy	ASTRAZENECA PLC (AZN)
azd9793 subcutaneous monotherapy	ASTRAZENECA PLC (AZN)
cetuximab	Sanofi (SNY)
Cetuximab	ELI LILLY & Co (LLY)
CTX131	CRISPR Therapeutics AG (CRSP)
eli-002 7p	Elicio Therapeutics, Inc. (ELTX)
gen1160	GENMAB A/S (GNMSF)
gen1160	Genmab A/S (GMAB)
gns561 + trametinib	Genfit S.A. (GNFT)
GTAEXS617	RECURSION PHARMACEUTICALS, INC. (RXRX)
hb-201 intravenous administration	HOOKIPA Pharma Inc. (HOOK)
HCW9218	ImmunityBio, Inc. (IBRX)
incagn02385	Incyte Corp. (INCY)
incagn02390	Incyte Corp. (INCY)
ino-9012	INOVIO PHARMACEUTICALS, INC. (INO)
leucovorin	GH Research PLC (GHRS)
LY3537982	ELI LILLY & Co (LLY)
micvotabart pelidotin	Pyxis Oncology, Inc. (PYXS)
osimertinib	Genprex, Inc. (GNPX)
otx-2002	Omega Therapeutics, Inc. (OMGA)
PF-08634404	PFIZER INC (PFE)
platinum-based chemotherapy	Genprex, Inc. (GNPX)
PSV359	Perspective Therapeutics, Inc. (CATX)
quaratusugene ozeplasmid	Genprex, Inc. (GNPX)
will receive hh-009	China Health Industries Holdings, Inc. (CHHE)

Phase 2/Phase 3(15)

Drug	Company
azd5851	ASTRAZENECA PLC (AZN)
BNT113	BioNTech SE (BNTX)
CAPOX	BRISTOL MYERS SQUIBB CO (BMY)
chemotherapy	PFIZER INC (PFE)
ficerafusp alfa	Bicara Therapeutics Inc. (BCAX)
fluoropyrimidine-	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
FOLFOX	BRISTOL MYERS SQUIBB CO (BMY)
folinic acid/ leucovorina	AbbVie Inc. (ABBV)
hb-202/hb-201 alternating 2-vector therapy	HOOKIPA Pharma Inc. (HOOK)
inbrx-106	Inhibrx Biosciences, Inc. (INBX)
navlimetostat	BRISTOL MYERS SQUIBB CO (BMY)
nogapendekin alfa	GH Research PLC (GHRS)
pd-1 inhibitor	BIOSTAR PHARMACEUTICALS, INC. (BSPM)
Pemetrexed	AbbVie Inc. (ABBV)
utidelone	BIOSTAR PHARMACEUTICALS, INC. (BSPM)

Phase 4(50)

Drug	Company
5-Flurouracil	Merus N.V. (MRUS)
5-FU	KYNTRA BIO INC. (KYNB)
Abiraterone	KYNTRA BIO INC. (KYNB)
Abiraterone acetate 250 mg or 500 mg tablets	KYNTRA BIO INC. (KYNB)
adjuvant chemotherapy	Merus N.V. (MRUS)
Androgen Deprivation Therapy	Royalty Pharma plc (RPRX)
Androgen-deprivation Therapy	Royalty Pharma plc (RPRX)
Apalutamide	KYNTRA BIO INC. (KYNB)
Avelumab	ENANTA PHARMACEUTICALS INC (ENTA)
Baxdrostat and dapagliflozin	Travere Therapeutics, Inc. (TVTX)
bms-986463	BRISTOL MYERS SQUIBB CO (BMY)
bms-986489	BRISTOL MYERS SQUIBB CO (BMY)
bms-986506	BRISTOL MYERS SQUIBB CO (BMY)
Botulinum toxin type A	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 100U	Revance Therapeutics, Inc. (RVNC)
Botulinum Toxin Type A 200U	Revance Therapeutics, Inc. (RVNC)
Brachytherapy	KYNTRA BIO INC. (KYNB)
CAPOX chemotherapy	Merus N.V. (MRUS)
Cetuximab	IGM Biosciences, Inc. (IGMS)
Chemotherapy	Merus N.V. (MRUS)
Chemotherapy Regimen	Merus N.V. (MRUS)
Concurrent chemotherapy	Merus N.V. (MRUS)
Conditioning chemotherapy	Merus N.V. (MRUS)
CPT-11	IGM Biosciences, Inc. (IGMS)
Dapagliflozin along with standard medical therapy	Travere Therapeutics, Inc. (TVTX)
Dapagliflozin Propanediol	Travere Therapeutics, Inc. (TVTX)
Darolutamide	KYNTRA BIO INC. (KYNB)
Darolutamide 300 mg tablets	KYNTRA BIO INC. (KYNB)
Diclofenac Potassium	Assertio Holdings, Inc. (ASRT)
Enfortumab Vedotin	Fulgent Genetics Inc. (FLGT)
Fianlimab	ENANTA PHARMACEUTICALS INC (ENTA)
FOLFOX chemotherapy	Merus N.V. (MRUS)
High dose potent statin	ENANTA PHARMACEUTICALS INC (ENTA)
Leucovorin Calcium	IGM Biosciences, Inc. (IGMS)
Leuprolide	Myovant Sciences Ltd. (MYOV)
Lutetium Lu 177 Vipivotide Tetraxetan	Novartis AG (NVS)
Lymphodepletion Chemotherapy	Merus N.V. (MRUS)
monalizumab	GH Research PLC (GHRS)
Monalizumab	ASTRAZENECA PLC (AZN)
Montelukast	Structure Therapeutics Inc. (GPCR)
Pemetrexed	ASTRAZENECA PLC (AZN)
Platinum chemotherapy	Merus N.V. (MRUS)
Ramucirumab	ENANTA PHARMACEUTICALS INC (ENTA)
Single agent chemotherapy	Merus N.V. (MRUS)
Single Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
Sodium Thiosulfate	ENANTA PHARMACEUTICALS INC (ENTA)
SOX chemotherapy	Merus N.V. (MRUS)
Tandem 3 Cycle Intensive Chemotherapy	Merus N.V. (MRUS)
tislelizumab	GH Research PLC (GHRS)
Zibotentan/Dapagliflozin FDC	Travere Therapeutics, Inc. (TVTX)

Compare drugs

abrilada vs afinitor abrilada vs Alinity® family abrilada vs Alinity® family of instruments

Frequently asked questions

How many drugs are in development for CIN?

BioSniper tracks 1001 drugs in development for CIN across 242 companies.

How many clinical trials target CIN?

There are 1 clinical trial targeting CIN tracked by BioSniper.

Deep-dive into CIN

Full trial data, competitive analysis, and AI-powered pipeline tracking.

Start Free Analysis